Reported Reactions

Adverse event reports that FDA received

  • Search
  • Watch list

April 2020 adverse event reports that FDA received in the month

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on . The data have the reports that FDA received through .

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.

Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on .

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports received

In April 2020, FDA received 122,399 drug adverse event reports. In April 2019, FDA received 119,984.

In April 2020, FDA received 107,484 medical device reports. In April 2019, FDA received 99,431.

By drug reports received, April 2020 was number 5 of the 12 months of 2020. FDA received 121,121 drug reports a month on average in the 12 months before April 2020.

Receive date

A month is the month in which FDA first received the report, not the month of the event. A report about an event of an earlier year is in the month in which it came to FDA.

Data version

FAERS release of 29 Oct 2026. MAUDE release of 23 Oct 2026.

Drug reports, three years

Drug reports that FDA received each month, 36 months to April 2020
0100,000200,000201820192020

Drugs in the reports

The table has the 136 drug pages with 250 or more reports in April 2020. The rows are in order of name. A drug page with fewer reports is not in the table.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Drugs that the reports of April 2020 name as a suspect product, in order of name
DrugReports in the month
Acetaminophen277
Actemra734
Aimovig1,255
Ambrisentan295
Amlodipine324
Apixaban478
Arava330
Atripla673
Avastin789
Azathioprine280
Breo Ellipta264
Bydureon Bcise309
Capecitabine460
Carboplatin522
Cimzia305
Cisplatin348
Clozapine442
Clozaril318
Cosentyx2,243
Creon347
Cyclophosphamide902
Cytarabine305
Dexamethasone764
Diclofenac269
Docetaxel397
Doxorubicin345
Doxorubicin hydrochloride408
Duodopa255
Dupixent1,860
Eligard321
Eliquis674
Emgality361
Enbrel1,715
Entresto974
Epidiolex252
Erivedge439
Esbriet323
Etoposide465
Fentanyl279
Finasteride346
Furosemide421
Gabapentin579
Gilenya562
Humalog499
Humira2,555
Hydrocodone bitartrate and acetaminophen266
Hydroxychloroquine384
Hydroxychloroquine sulfate430
Ibrance864
Ibuprofen408
Imbruvica546
Infliximab772
Ingrezza343
Insulin glargine297
Jakafi602
Keytruda296
Kisqali253
Lantus Solostar348
Latanoprost563
Leflunomide578
Levetiracetam253
Liletta1,405
Lyrica509
Metformin469
Methotrexate1,791
Methotrexate sodium488
Methylprednisolone315
Mirena362
Morphine sulfate461
Mycophenolate mofetil645
Neulasta1,174
Nexium959
Nexium 24HR433
Nexplanon263
Nivolumab404
Ocrevus264
Olanzapine251
Omeprazole700
Opsumit390
Orencia859
Orilissa377
Otezla2,148
Oxaliplatin322
Oxycodone hydrochloride879
OxyContin1,105
Paclitaxel348
Pantoprazole507
Pantoprazole sodium558
Paracetamol259
Pataday497
Patanol267
Plaquenil258
Pomalyst689
Prednisolone638
Prednisone1,395
Pregabalin252
Prevacid752
Prevacid 24 HR394
Prilosec916
Prilosec OTC466
Prolia386
Quetiapine297
Remicade734
Remodulin267
Repatha781
Revlimid2,146
Rituxan286
Rituximab1,164
Rivaroxaban270
Sertraline260
Simponi481
Stelara830
Stribild262
Sulfasalazine483
Symbicort296
Tacrolimus693
Taltz256
Tecfidera659
Timolol273
Tramadol318
Trelegy Ellipta278
Trikafta846
Trulicity489
Truvada1,261
Tysabri493
Venclexta277
Viagra290
Vincristine414
Vincristine sulfate493
Viread1,224
Vivitrol1,023
Xarelto376
Xeljanz2,023
Xyrem279
Zaditor313
Zejula255

Reaction terms in the reports

The table has the 143 reaction terms with 500 or more reports in April 2020. The rows are in order of name. One report can record more than one term.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Reaction terms that the drug reports of April 2020 record, in order of name
Reaction term (MedDRA) and plain meaningReports in the month
Abdominal discomfortstomach discomfort1,000
Abdominal distensiona bloated abdomen544
Abdominal painstomach or belly pain1,174
Abdominal pain upperupper stomach pain1,106
Accidental exposure to product704
Acneacne3,349
Acute kidney injurysudden loss of kidney function1,507
Alopeciahair loss1,189
Anaemialow red blood cells959
Anxietyanxiety1,608
Arthralgiajoint pain2,287
Astheniaweakness or lack of energy1,806
Asthmaasthma637
Back painback pain1,216
Blood glucose increasedraised blood sugar reading934
Blood pressure increaseda raised blood pressure reading1,044
Bone density decreased1,331
Bone loss902
Cerebrovascular accidentstroke674
Chest discomfortchest discomfort599
Chest painchest pain834
Chillschills or shivering563
Chronic kidney diseaselong-term kidney disease2,144
Condition aggravatedthe condition being treated got worse2,565
Confusional stateconfusion815
Constipationconstipation1,253
Coronavirus infection1,088
Coughcough1,857
Covid-19COVID-19 infection547
Deaththe patient died; cause not stated by this term5,057
Decreased appetitereduced appetite1,235
Dehydrationdehydration631
Depressionlow mood1,098
Device expulsionthe device came out770
Device issuea problem with the device548
Device malfunctionthe device did not work properly535
Device use errora mistake in using the device545
Diarrhoealoose or frequent stools3,499
Disease progressionthe disease advanced545
Dizzinesslight-headedness or unsteadiness2,338
Drug abusemisuse of a medicine574
Drug dependencedependence on a medicine1,441
Drug hypersensitivityan allergic-type reaction (the term names a medicine)1,418
Drug ineffectivethe medicine did not work as expected14,430
Drug interactionan interaction between medicines872
Drug intolerancethe medicine was not tolerated754
Dry skindry skin4,055
Dyspnoeashortness of breath3,283
Emotional distressemotional distress640
Erythemaskin redness3,788
Falla fall1,746
Fatiguetiredness4,123
Feeling abnormalfeeling odd or not right1,369
Gait disturbancedifficulty walking1,004
General physical health deteriorationgeneral decline in health667
Haemoglobin decreasedlow haemoglobin536
Haemorrhagebleeding505
Headachehead pain3,579
Hospitalisationadmission to hospital892
Hyperhidrosisexcessive sweating591
Hypersensitivityan allergic-type reaction1,807
Hypertensionhigh blood pressure1,109
Hypoaesthesianumbness680
Hypotensionlow blood pressure976
Inappropriate schedule of product administrationthe product was taken at the wrong times3,142
Incorrect dose administeredthe wrong dose was given1,041
Infectionan infection, type not specified800
Influenzaflu821
Injection site painpain where the injection was given1,330
Insomniadifficulty sleeping1,379
Intentional product misusedeliberate use not as intended512
Intentional product use issuedeliberate use not as intended1,324
Joint swellinga swollen joint767
Loss of consciousnesspassing out630
Malaisegeneral feeling of being unwell2,684
Malignant neoplasm progression557
Maternal exposure during pregnancythe mother took the medicine during pregnancy530
Memory impairmentmemory problems762
Migrainemigraine586
Multiple fractures726
Muscle spasmsmuscle cramps959
Muscular weaknessmuscle weakness505
Musculoskeletal stiffnessstiffness in muscles or joints604
Myalgiamuscle pain777
Myocardial infarctionheart attack527
Nasopharyngitisa cold1,035
Nauseafeeling sick3,913
Neuropathy peripheralnerve damage in hands or feet622
Neutropenialow neutrophils, a type of white blood cell763
No adverse eventno adverse event was reported854
Off label useused for a purpose or in a way not on the label5,650
Oropharyngeal painsore throat677
Osteonecrosis967
Osteoporosisthinning of the bones686
Overdosea dose above the recommended amount1,939
Painpain, site not specified3,832
Pain in extremitypain in an arm or leg1,507
Pain of skin1,085
Palpitationsawareness of the heartbeat521
Paraesthesiatingling or pins and needles691
Peripheral swellingswelling of the arms or legs1,088
Platelet count decreasedlow platelet count579
Pneumonialung infection2,080
Product dose omissiona dose was missed2,867
Product dose omission issuea dose was missed1,018
Product use in unapproved indicationused for a purpose not on the label2,306
Product use issuea problem in how the product was used1,317
Pruritusitching2,825
Psoriasispsoriasis, a skin condition1,236
Pyrexiafever1,988
Rashskin rash3,395
Renal failurekidney failure1,530
Renal impairmentreduced kidney function545
Renal injury831
Rheumatoid arthritisrheumatoid arthritis, an inflammatory joint disease751
Seizurea fit or convulsion742
Sepsisa severe body-wide response to infection561
Sinusitissinus infection632
Skin burning sensationburning skin3,064
Skin exfoliationpeeling skin1,828
Skin irritationirritated skin2,224
Somnolencedrowsiness983
Stressstress535
Swellingswelling524
Therapeutic product effect decreased564
Therapeutic product effect incomplete913
Therapy interrupted597
Thrombocytopenialow platelets567
Tooth loss663
Toxicity to various agentspoisoning or toxic effect of one or more substances698
Treatment failurethe treatment did not work2,051
Tremorshaking799
Underdoseless than the intended dose848
Urinary tract infectionbladder or urinary infection992
Urticariahives1,029
Vision blurredblurred vision561
Visual impairmentreduced vision749
Vomitingbeing sick2,210
Weight decreasedweight loss1,571
Weight increasedweight gain1,207
White blood cell count decreasedlow white cell count581
Wrong technique in device usage process656
Wrong technique in product usage processthe product was used in the wrong way1,271

Devices in the reports

The table has the 39 device pages with 250 or more reports in April 2020. The rows are in order of name. A device page with fewer reports is not in the table.

FDA says:

MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices.

Source: openFDA, Manufacturer and User Facility Device Experience. The site read the page on .

Device brand names that the device reports of April 2020 name, in order of name
Brand nameReports in the month
630G Insulin PUMP MMT-1715K 630G BLACK MG1,778
630G Insulin PUMP MMT-1715KL 630G259
640G Insulin Pump MMT-1711K1,343
640G Insulin Pump MMT-1712K1,818
670G Insulin Pump MMT-1780KL772
Bard Max-Core Disposable Core Biopsy Instrument452
Biohorizons Dental Implant304
CapSureFix Novus Lead MRI SureScan806
Dexcom G5 Mobile Continuous Glucose Monitoring System734
Dexcom G6 Continuous Glucose Monitoring System11,086
Emblem Mri S-Icd270
EnCor Biopsy Probe340
Essure3,584
Implantable Collamer Lens Icl300
Ingevity Mri782
Inspira Textured Silicone Gel Filled Breast Implant303
LifeVest WCD 4000 System1,143
MENTOR MemoryGel Breast Implant277
Natura1,243
Navio Handpiece257
Octrode Lead Kit, 60cm Length256
Omnipod DASH Insulin Management System355
Omnipod Insulin Management System749
OmniPod Insulin Pump359
Paradigm REAL-Time REVEL Insulin Infusion Pump MMT-723LNAS307
Pump Mmt-1715km 630g 3ml Black Medi292
Pump MMT-1780KPK 670G Pathway Black MG5,664
Pump Mmt-1782k 670g V4 11 Mm333
Spectrum Infusion Pump362
Sprint Quattro Secure S MRI SureScan282
Style 68 Saline Filled Breast Implant299
T Slim G5 System774
t:slim G4 system423
t:slim Insulin Delivery System272
t:slim X2 Insulin Pump641
t:slim X2 Insulin Pump with Basal-IQ Technology4,185
t:slim X2 Insulin Pump with Interoperable Technology1,424
Tendril Sts281
V60 Ventilator384

Cite this page

Reported Reactions. April 2020: adverse event reports received by FDA. https://reportedreactions.com/month/2020-04/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of . Reports received through .

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The device counts come from the openFDA Device Adverse Event (MAUDE) bulk files, release of 23 Oct 2026. The files have the reports that FDA received through 30 Sep 2026. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

Can the count for April 2020 change?

Yes. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases. This page has the count of the openFDA release of 29 Oct 2026: 122,399 drug reports.

Does a month with many reports mean that something occurred in that month?

Not by itself. The date is the date on which FDA received the report, not the date of the event. FDA says:

Many factors can influence whether or not an event will be reported, such as the time a product has been marketed and publicity about an event.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

How does a person report an adverse event?

FDA runs MedWatch, a program that takes voluntary reports from health professionals, patients and consumers. The guide on how to report has the links.